Lawrence F. Eichenfield

Guest Editor for the following articles:

Mar
2017
Vol. 36. No. 2

Addressing the Immunopathogenesis of Atopic Dermatitis: Advances in Topical and Systemic Treatment

Lawrence F. Eichenfield, MD | Linda Stein Gold, MD

Several immunologic mediators—phosphodiesterase (PDE), interleukin (IL), small molecules, and Janus kinase—have been implicated in the pathogenesis of atopic dermatitis, and evidence has shown that blocking these mediators can help modify the disease process.

Eichenfield LF, Stein Gold LF. Addressing the immunopathogenesis of atopic dermatitis: advances in topical and systemic treatment. Sem Cutan Med Surg. 2017;36(Suppl 2):S45-S48. https://doi.org/10.12788/j.sder.2017.012.

If you would like to complete the CME portion of this Supplement, please click here.

MORE
Sep
2017
Vol. 36. No. 3

Atopic dermatitis: addressing allergy, infection, itch and complementary therapies

Adam Friedman, MD | Andrea Waldman, MD | Dawn Marie Davis, MD | Jeffrey Bienstock, MD | Jennifer LeBovidge, PhD | Jonathan Spergel, PhD | Jusleen Ahluwalia, MD | Luz Fonacier, MD | Nathan Jetter, BS | Peter Lio, MD | Peter Y Ong, MD | Sharon E Jacob, MD | Stuart Cohen, MD
This review summarizes allergy, infections, itch in AD, and discusses various alternative and complementary therapies.
MORE